First-trimester screening for trisomy 21 in twin pregnancy: Does the addition of biochemistry make an improvement?

Prenatal Diagnosis

Volumn 25, Issue 12, 2005, Pages 1156-1161

  Goncé, Anna ^a,b   Borrell, Antoni ^a   Fortuny, Albert ^a   Casals, Elena ^a   Martínez, M Angels ^a   Mercadé, Imma ^a   Cararach, Vicenç ^a   Vanrell, Joan Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Combined Test; First trimester screening; Nuchal translucency; Trisomy 21; Twins

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BIOCHEMISTRY; CASE REPORT; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FETUS; FETUS ECHOGRAPHY; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HORMONE DETERMINATION; HUMAN; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; TRISOMY 21; TWIN PREGNANCY;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI SAMPLING; DISEASES IN TWINS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, MULTIPLE; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 29544441280     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1304     Document Type: Article

References (32)

1. Bersinger NA, Noble P, Nicolaides KH. 2003. First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies. Prenat Diagn 23: 157-162.
2. Bindra R, Heart V, Liao A, Spencer K, Nicolaides KH. 2002. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15030 pregnancies. Ultrasound Obstet Gynecol 20: 219-225.
3. Borrell A, Casals E, Fortuny A, et al. 2004. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 24: 541-545.
4. Casals E, Aibar C, Martínez JM, et al. 1999. First trimester biochemical markers for Down Syndrome. Prenat Diagn 19: 505-512.
5. Cuckle H. 1998. Down's syndrome screening in twins. J Med Screen 5: 3-4.
6. Ferguson Smith M, Arbuzova S, Benn P, et al. 2004. Down Syndrome Screening. A Position Statement from the Scientific Committee of the International Down Syndrome Screening Group.
7. Jamar M, Lemarchal C, Lemaire V, Koulischer L, Bours V. 2003. A low rate of trisomy 21 in twin-pregnancies: a cytogenetics retrospective study of 278 cases. Genet Couns 14(4): 395-400.
8. Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW, Macri JN. 2000. First trimester Down Syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 96: 207-213.
9. Mashiach R, Orr-Urtreger A, Yaron Y. 2004. A comparison between maternal serum free B-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies. Fetal Diagn Ther 19: 174-177.
10. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. 1999. Comparison of nuchal translucency measurement and second trimester triple serum screening in twins versus singleton pregnancies. Prenat Diagn 19: 727-731.
11. Maymon R, Jauniaux E, Holmes A, Wiener YM, Dreazen E, Herman A. 2001. Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins. Human Reproduction 16: 1999-2004.
12. Meyers C, Adam R, Dungan J, Prenger V. 1997. Aneuploidy in twin gestations: when is maternal age advanced? Obstet Gynecol 89: 248-251.
13. Muller F, Dreux S, Dupoizat H, et al. 2003. Second trimester Down Syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23: 331-335.
14. Neveux L, Palomaki G, Knight G, Haddow J. 1996. Multiple marker screening for Down Syndrome in twin pregnancies. Prenat Diagn 16: 29-34.
15. Nicolaides KH, Brizot ML, Snijders RJM. 1994. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynecol 101: 782-786.
16. Niemimaa M, Suonpaa M, Heinonen S, Seppala M, Bloigu R, Ryynanen M. 2002. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 22: 183-185.
17. O'Brien JE, Dvorin E, Yaron Y, et al. 1997. Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down Syndrome screening calculations. Am J Med Genet 73: 109-112.
18. Odibo AO, Lawrence-Cleary K, Macones GA. 2003. Screening for aneuploidy in twins and higher-order multiples: Is first-trimester nuchal translucency the solution? Obstet Gynecol Surv 58(9): 609-614.
19. Orlandi F, Rossi C, Allegra A, et al. 2002. First trimester screening with free β-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
20. Rodis JF, Egan JFX, Craffey A, Ciarleglio L, Greenstein RM, Scorza WE. 1990. Calculated risk of chromosomal abnormalities in twin gestations. Obstet Gynecol 76: 1037-1041.
21. 6 Weeks Scan. Fetal Medicine Foundation: London; 95-112.
22. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. 1996. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynecol 103: 999-1003.
23. Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. 2000. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod 15(9): 2008-2010.
24. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. 1996. The lambda sign at 10-14 weeks gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7: 421-423.
25. Spencer K. 2000. Screening for trisomy 21 in twin pregnancies in the first trimester using free B-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 20: 91-95.
26. Spencer K. 2001. Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free B-hCG or PAPP-A levels? Prenat Diagn 21: 715-717.
27. Spencer K, Nicolaides KH. 2003a. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in one-stop clinic: a review of three years prospective experience. Br J Obstet Gynecol 110: 281-286.
28. Spencer K, Nicolaides KH. 2003b. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Br J Obstet Gynecol 110: 276-280.
29. Spencer K, Salonen R, Muller F. 1994. Down's Syndrome screening in multiple pregnancies using alpha fetoprotein and free beta hCG. Prenat Diagn 14: 537-542.
30. Wald NJ, Rish S, Hackshaw AK. 2003. Combining nuchal translucency and serum markes in prenatal screening for Down Syndrome in twin pregnancies. Prenat Diagn 23: 588-592.
31. Wald N, Cuckle H, Wu TS, George L. 1991. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's Syndrome. Br J Obstet Gynecol 98: 905-908.
32. Wapner R, Thom E, Simpson JL, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349: 1405-1413.